vs

Side-by-side financial comparison of FIDELITY D & D BANCORP INC (FDBC) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.

FIDELITY D & D BANCORP INC is the larger business by last-quarter revenue ($24.4M vs $20.6M, roughly 1.2× Pulmonx Corp). FIDELITY D & D BANCORP INC runs the higher net margin — 32.5% vs -66.3%, a 98.9% gap on every dollar of revenue. On growth, FIDELITY D & D BANCORP INC posted the faster year-over-year revenue change (15.0% vs -8.7%). Over the past eight quarters, FIDELITY D & D BANCORP INC's revenue compounded faster (11.8% CAGR vs -0.5%).

Fidelity D & D Bancorp Inc is a US-based regional bank holding company primarily operating in northeastern Pennsylvania. It offers a full range of retail and commercial banking services including deposit accounts, consumer and business loans, mortgage lending, and wealth management solutions, catering to individual consumers, small businesses and local community clients.

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

FDBC vs LUNG — Head-to-Head

Bigger by revenue
FDBC
FDBC
1.2× larger
FDBC
$24.4M
$20.6M
LUNG
Growing faster (revenue YoY)
FDBC
FDBC
+23.7% gap
FDBC
15.0%
-8.7%
LUNG
Higher net margin
FDBC
FDBC
98.9% more per $
FDBC
32.5%
-66.3%
LUNG
Faster 2-yr revenue CAGR
FDBC
FDBC
Annualised
FDBC
11.8%
-0.5%
LUNG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FDBC
FDBC
LUNG
LUNG
Revenue
$24.4M
$20.6M
Net Profit
$7.9M
$-13.7M
Gross Margin
77.9%
Operating Margin
37.7%
-40.9%
Net Margin
32.5%
-66.3%
Revenue YoY
15.0%
-8.7%
Net Profit YoY
36.1%
5.5%
EPS (diluted)
$1.29
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDBC
FDBC
LUNG
LUNG
Q1 26
$20.6M
Q4 25
$24.4M
$22.6M
Q3 25
$23.5M
$21.5M
Q2 25
$23.3M
$23.9M
Q1 25
$22.0M
$22.5M
Q4 24
$21.2M
$23.8M
Q3 24
$20.4M
$20.4M
Q2 24
$19.7M
$20.8M
Net Profit
FDBC
FDBC
LUNG
LUNG
Q1 26
$-13.7M
Q4 25
$7.9M
$-10.4M
Q3 25
$7.3M
$-14.0M
Q2 25
$6.9M
$-15.2M
Q1 25
$6.0M
$-14.4M
Q4 24
$5.8M
$-13.2M
Q3 24
$5.0M
$-14.1M
Q2 24
$4.9M
$-15.3M
Gross Margin
FDBC
FDBC
LUNG
LUNG
Q1 26
77.9%
Q4 25
77.6%
Q3 25
74.7%
Q2 25
72.1%
Q1 25
72.5%
Q4 24
74.0%
Q3 24
73.7%
Q2 24
73.7%
Operating Margin
FDBC
FDBC
LUNG
LUNG
Q1 26
-40.9%
Q4 25
37.7%
-43.8%
Q3 25
36.5%
-66.9%
Q2 25
35.5%
-62.0%
Q1 25
32.2%
-64.6%
Q4 24
31.4%
-56.5%
Q3 24
28.2%
-69.3%
Q2 24
28.9%
-75.2%
Net Margin
FDBC
FDBC
LUNG
LUNG
Q1 26
-66.3%
Q4 25
32.5%
-46.1%
Q3 25
31.2%
-64.9%
Q2 25
29.7%
-63.6%
Q1 25
27.2%
-64.1%
Q4 24
27.5%
-55.4%
Q3 24
24.3%
-69.4%
Q2 24
25.0%
-73.7%
EPS (diluted)
FDBC
FDBC
LUNG
LUNG
Q1 26
$-0.33
Q4 25
$1.29
$-0.25
Q3 25
$1.27
$-0.34
Q2 25
$1.27
$-0.38
Q1 25
$1.03
$-0.36
Q4 24
$1.00
$-0.33
Q3 24
$0.86
$-0.36
Q2 24
$0.86
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDBC
FDBC
LUNG
LUNG
Cash + ST InvestmentsLiquidity on hand
$148.1M
$61.6M
Total DebtLower is stronger
$37.3M
Stockholders' EquityBook value
$238.9M
$45.8M
Total Assets
$2.7B
$120.0M
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDBC
FDBC
LUNG
LUNG
Q1 26
$61.6M
Q4 25
$148.1M
$69.8M
Q3 25
$142.2M
$76.5M
Q2 25
$165.5M
$75.5M
Q1 25
$211.2M
$74.6M
Q4 24
$83.4M
$70.9M
Q3 24
$120.2M
$63.3M
Q2 24
$78.1M
$63.5M
Total Debt
FDBC
FDBC
LUNG
LUNG
Q1 26
$37.3M
Q4 25
$37.1M
Q3 25
$37.1M
Q2 25
$37.1M
Q1 25
$37.2M
Q4 24
$37.2M
Q3 24
$37.2M
Q2 24
$37.2M
Stockholders' Equity
FDBC
FDBC
LUNG
LUNG
Q1 26
$45.8M
Q4 25
$238.9M
$54.1M
Q3 25
$229.2M
$60.0M
Q2 25
$217.9M
$69.1M
Q1 25
$211.7M
$77.7M
Q4 24
$204.0M
$85.8M
Q3 24
$207.3M
$93.9M
Q2 24
$195.7M
$101.2M
Total Assets
FDBC
FDBC
LUNG
LUNG
Q1 26
$120.0M
Q4 25
$2.7B
$129.3M
Q3 25
$2.7B
$138.3M
Q2 25
$2.7B
$147.2M
Q1 25
$2.7B
$150.7M
Q4 24
$2.6B
$162.8M
Q3 24
$2.6B
$167.4M
Q2 24
$2.5B
$172.6M
Debt / Equity
FDBC
FDBC
LUNG
LUNG
Q1 26
0.82×
Q4 25
0.69×
Q3 25
0.62×
Q2 25
0.54×
Q1 25
0.48×
Q4 24
0.43×
Q3 24
0.40×
Q2 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDBC
FDBC
LUNG
LUNG
Operating Cash FlowLast quarter
$42.4M
Free Cash FlowOCF − Capex
$24.8M
FCF MarginFCF / Revenue
101.7%
Capex IntensityCapex / Revenue
71.9%
Cash ConversionOCF / Net Profit
5.34×
TTM Free Cash FlowTrailing 4 quarters
$45.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDBC
FDBC
LUNG
LUNG
Q1 26
Q4 25
$42.4M
$-7.1M
Q3 25
$8.4M
$-8.2M
Q2 25
$12.6M
$-3.9M
Q1 25
$11.7M
$-13.2M
Q4 24
$29.6M
$-6.7M
Q3 24
$9.1M
$-7.2M
Q2 24
$8.7M
$-5.8M
Free Cash Flow
FDBC
FDBC
LUNG
LUNG
Q1 26
Q4 25
$24.8M
$-7.1M
Q3 25
$2.2M
$-8.3M
Q2 25
$6.9M
$-4.0M
Q1 25
$11.5M
$-13.5M
Q4 24
$24.9M
$-6.8M
Q3 24
$7.8M
$-7.7M
Q2 24
$7.2M
$-6.2M
FCF Margin
FDBC
FDBC
LUNG
LUNG
Q1 26
Q4 25
101.7%
-31.4%
Q3 25
9.3%
-38.4%
Q2 25
29.6%
-16.6%
Q1 25
52.3%
-60.0%
Q4 24
117.3%
-28.8%
Q3 24
38.1%
-37.6%
Q2 24
36.6%
-30.0%
Capex Intensity
FDBC
FDBC
LUNG
LUNG
Q1 26
Q4 25
71.9%
0.1%
Q3 25
26.5%
0.4%
Q2 25
24.4%
0.2%
Q1 25
0.8%
1.3%
Q4 24
22.0%
0.5%
Q3 24
6.3%
2.0%
Q2 24
7.5%
2.3%
Cash Conversion
FDBC
FDBC
LUNG
LUNG
Q1 26
Q4 25
5.34×
Q3 25
1.15×
Q2 25
1.82×
Q1 25
1.95×
Q4 24
5.07×
Q3 24
1.83×
Q2 24
1.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons